Delivery Order SPE2DB24D1021-SPE2DB25FEYRG
Award Date 7/15/25
Potential Completion Date 7/16/25
Potential Value $1.1K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order federal contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Losartan-HCTZ 100-12.5 mg tablets in 90-count packages, with a ceiling value of $1,544.23. The contract is a firm fixed-price delivery order, without any set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a significant Indefinite...
- This is a $8,281.55 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the supply of Losartan-HCTZ 100-12.5 mg tablets. The contract has an ultimate completion date of July 19, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which serves as a primary...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Losartan-HCTZ 50-12.5 mg tablets in 90-count bottles, with a ceiling value of $1,940.32 and a performance period extending through May 16, 2025. This award is not associated with a set-aside program. AmerisourceBergen Drug Corp holds a significant Indefinite...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,156.16, is for the delivery of Losartan-HCTZ 50-12.5 mg tablets in 90-count bottles. The contract has an ultimate completion date of March 12, 2025 and is a Firm Fixed Price Delivery Order. This contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug...
- This is a delivery order awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. The $6,725.05 firm fixed-price contract is for the delivery of Losartan-HCTZ 50-12.5 mg tablets in 90-count packages. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with DLA Troop Support Medical, which serves as a...
- This is a $30,269.96 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Losartan-HCTZ 100-25 mg tablets in 90-count packages. The contract has an ultimate completion date of March 26, 2025. This delivery order is placed against Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $2,988.53 firm fixed price delivery order is for the supply of Losartan-HCTZ 50-12.5 mg tablets in 90-count packages. The delivery order falls under a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp, which has a potential value of $999,999,999.00 and a performance period through...
- This is a $2,494.79 firm fixed price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of Losartan-HCTZ 50-12.5 mg tablets. The contract has an ultimate completion date of July 14, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp, a for-profit organization based in Conshohocken, Pennsylvania, holds a substantial $999,999,999 Indefinite Delivery Contract (IDC) with the...
- This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,103.05, is for the delivery of Losartan-HCTZ 100-12.5 mg tablets. It is a Firm Fixed Price Delivery Order contract with an ultimate completion date of July 29, 2024. The contract is not designated as a set-aside and is an open competition award. Amerisourcebergen Drug Corp is the prime contractor...
- This is a delivery order (contract) awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 1,000 units of the drug Losartan-HCTZ 50-12.5 mg tablets, a medication used to treat high blood pressure. The contract has a firm fixed price of $17,107.69 and a completion date of February 16, 2024. This contract is not designated as a set-aside contract. AmerisourceBergen holds a...
- SPE2DB24D1021Indefinite Delivery Contract
- SPE2DB24D1021-SPE2DB25FEYRGDelivery Order
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of LOSARTAN-HCTZ 50-12.5 MG TAB 90S, a prescription medication, with a total ceiling value of $1,142.45. The contract is a firm fixed-price delivery order with a performance period through July 16, 2025. This award is not associated with any set-aside program. Amerisourcebergen Drug Corp is the prime contractor and there is no information provided about any subcontractors. The contract supports the DLA's medical supply needs for the U.S. Department of Defense and other government agencies.
Generated 10/14/25, 10:45 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 7/15/25 |